IL-1 and atherosclerosis: a murine twist to an evolving human story.
Inflammation is a critical component of atherosclerosis. IL-1 is a classic proinflammatory cytokine that has been linked to atherosclerosis. A clinical trial has been launched in which an antibody specific for IL-1β is being studied for its effects on cardiovascular events in patients with atherosclerosis. In this issue of the JCI, Alexander et al. report that mice lacking the receptor for IL-1 unexpectedly have features of advanced atherosclerosis that suggest the atherosclerotic plaques may be less stable. These findings illustrate the complexity of inflammatory pathways in atherosclerosis and suggest the need for careful calibration of antiinflammatory approaches to atherosclerosis.
Department of Medicine and Institute for Translational Medicine and Therapeutics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania 19104-5158, USA. rader@mail.med.upenn.edu
Daniel J
DJ
Rader
D000818:Animals; D005260:Female; D007375:Interleukin-1 / Q000502:physiology*; D058226:Plaque, Atherosclerotic / Q000209:etiology*
D007375:Interleukin-1